Pharmaceutical inhibition of mTORC1 with rapamycin restored autophagy initiation and ultimately suppressed the metastatic potential of IMPA2-silenced ccRCC cells in vitro and in vivo. Here, IMPA2 is linked to nonpapillary renal cell carcinoma.